Antibody Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 76 pages | ID: AC257F03413FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibody Drugs in global, including the following market information:

Global Antibody Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antibody Drugs Market Sales, 2017-2022, 2023-2028, (mg)

Global top five Antibody Drugs companies in 2021 (%)

The global Antibody Drugs market was valued at 131700 million in 2021 and is projected to reach US$ 237590 million by 2028, at a CAGR of 8.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibody Drugs include Novartis, Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (mg)

Global Antibody Drugs Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Antibody-Drug Conjugates
• Polyclonal Antibodies

Global Antibody Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (mg)

Global Antibody Drugs Market Segment Percentages, by Application, 2021 (%)

• Central Nervous System (CNS) Disorders
• Cancers
• Autoimmune Disorders
• Cardiovascular Diseases

Global Antibody Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (mg)

Global Antibody Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antibody Drugs revenues share in global market, 2021 (%)

Key companies Antibody Drugs sales in global market, 2017-2022 (Estimated), (mg)

Key companies Antibody Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Johnson & Johnson
• AbbVie
• Eli Lilly
• Pfizer
• Bayer
• GlaxoSmithKline
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY DRUGS OVERALL MARKET SIZE

2.1 Global Antibody Drugs Market Size: 2021 VS 2028
2.2 Global Antibody Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibody Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Antibody Drugs Players in Global Market
3.2 Top Global Antibody Drugs Companies Ranked by Revenue
3.3 Global Antibody Drugs Revenue by Companies
3.4 Global Antibody Drugs Sales by Companies
3.5 Global Antibody Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibody Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibody Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Antibody Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antibody Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibody Drugs Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Antibody-Drug Conjugates
  4.1.4 Polyclonal Antibodies
4.2 By Type - Global Antibody Drugs Revenue & Forecasts
  4.2.1 By Type - Global Antibody Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Antibody Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Antibody Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Antibody Drugs Sales & Forecasts
  4.3.1 By Type - Global Antibody Drugs Sales, 2017-2022
  4.3.2 By Type - Global Antibody Drugs Sales, 2023-2028
  4.3.3 By Type - Global Antibody Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Drugs Market Size, 2021 & 2028
  5.1.2 Central Nervous System (CNS) Disorders
  5.1.3 Cancers
  5.1.4 Autoimmune Disorders
  5.1.5 Cardiovascular Diseases
5.2 By Application - Global Antibody Drugs Revenue & Forecasts
  5.2.1 By Application - Global Antibody Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Antibody Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Antibody Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Antibody Drugs Sales & Forecasts
  5.3.1 By Application - Global Antibody Drugs Sales, 2017-2022
  5.3.2 By Application - Global Antibody Drugs Sales, 2023-2028
  5.3.3 By Application - Global Antibody Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Drugs Market Size, 2021 & 2028
6.2 By Region - Global Antibody Drugs Revenue & Forecasts
  6.2.1 By Region - Global Antibody Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Antibody Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Antibody Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Antibody Drugs Sales & Forecasts
  6.3.1 By Region - Global Antibody Drugs Sales, 2017-2022
  6.3.2 By Region - Global Antibody Drugs Sales, 2023-2028
  6.3.3 By Region - Global Antibody Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Antibody Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Antibody Drugs Sales, 2017-2028
  6.4.3 US Antibody Drugs Market Size, 2017-2028
  6.4.4 Canada Antibody Drugs Market Size, 2017-2028
  6.4.5 Mexico Antibody Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Antibody Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Antibody Drugs Sales, 2017-2028
  6.5.3 Germany Antibody Drugs Market Size, 2017-2028
  6.5.4 France Antibody Drugs Market Size, 2017-2028
  6.5.5 U.K. Antibody Drugs Market Size, 2017-2028
  6.5.6 Italy Antibody Drugs Market Size, 2017-2028
  6.5.7 Russia Antibody Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Antibody Drugs Market Size, 2017-2028
  6.5.9 Benelux Antibody Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Antibody Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Antibody Drugs Sales, 2017-2028
  6.6.3 China Antibody Drugs Market Size, 2017-2028
  6.6.4 Japan Antibody Drugs Market Size, 2017-2028
  6.6.5 South Korea Antibody Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Antibody Drugs Market Size, 2017-2028
  6.6.7 India Antibody Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Antibody Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Antibody Drugs Sales, 2017-2028
  6.7.3 Brazil Antibody Drugs Market Size, 2017-2028
  6.7.4 Argentina Antibody Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antibody Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Antibody Drugs Sales, 2017-2028
  6.8.3 Turkey Antibody Drugs Market Size, 2017-2028
  6.8.4 Israel Antibody Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Antibody Drugs Market Size, 2017-2028
  6.8.6 UAE Antibody Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Antibody Drugs Major Product Offerings
  7.1.4 Novartis Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Novartis Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Antibody Drugs Major Product Offerings
  7.2.4 Amgen Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Amgen Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Antibody Drugs Major Product Offerings
  7.3.4 Bristol-Myers Squibb Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 F. Hoffmann-La Roche
  7.4.1 F. Hoffmann-La Roche Corporate Summary
  7.4.2 F. Hoffmann-La Roche Business Overview
  7.4.3 F. Hoffmann-La Roche Antibody Drugs Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 F. Hoffmann-La Roche Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Antibody Drugs Major Product Offerings
  7.5.4 Johnson & Johnson Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 AbbVie
  7.6.1 AbbVie Corporate Summary
  7.6.2 AbbVie Business Overview
  7.6.3 AbbVie Antibody Drugs Major Product Offerings
  7.6.4 AbbVie Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 AbbVie Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Antibody Drugs Major Product Offerings
  7.7.4 Eli Lilly Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Eli Lilly Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Antibody Drugs Major Product Offerings
  7.8.4 Pfizer Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Pfizer Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Antibody Drugs Major Product Offerings
  7.9.4 Bayer Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Bayer Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Antibody Drugs Major Product Offerings
  7.10.4 GlaxoSmithKline Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Antibody Drugs Business Overview
  7.11.3 Sanofi Antibody Drugs Major Product Offerings
  7.11.4 Sanofi Antibody Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Sanofi Key News

8 GLOBAL ANTIBODY DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antibody Drugs Production Capacity, 2017-2028
8.2 Antibody Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTIBODY DRUGS SUPPLY CHAIN ANALYSIS

10.1 Antibody Drugs Industry Value Chain
10.2 Antibody Drugs Upstream Market
10.3 Antibody Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antibody Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antibody Drugs in Global Market
Table 2. Top Antibody Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibody Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibody Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Antibody Drugs Sales by Companies, (mg), 2017-2022
Table 6. Global Antibody Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibody Drugs Price (2017-2022) & (USD/mg)
Table 8. Global Manufacturers Antibody Drugs Product Type
Table 9. List of Global Tier 1 Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibody Drugs Sales (mg), 2017-2022
Table 15. By Type - Global Antibody Drugs Sales (mg), 2023-2028
Table 16. By Application – Global Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antibody Drugs Sales (mg), 2017-2022
Table 20. By Application - Global Antibody Drugs Sales (mg), 2023-2028
Table 21. By Region – Global Antibody Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibody Drugs Sales (mg), 2017-2022
Table 25. By Region - Global Antibody Drugs Sales (mg), 2023-2028
Table 26. By Country - North America Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibody Drugs Sales, (mg), 2017-2022
Table 29. By Country - North America Antibody Drugs Sales, (mg), 2023-2028
Table 30. By Country - Europe Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibody Drugs Sales, (mg), 2017-2022
Table 33. By Country - Europe Antibody Drugs Sales, (mg), 2023-2028
Table 34. By Region - Asia Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibody Drugs Sales, (mg), 2017-2022
Table 37. By Region - Asia Antibody Drugs Sales, (mg), 2023-2028
Table 38. By Country - South America Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibody Drugs Sales, (mg), 2017-2022
Table 41. By Country - South America Antibody Drugs Sales, (mg), 2023-2028
Table 42. By Country - Middle East & Africa Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibody Drugs Sales, (mg), 2017-2022
Table 45. By Country - Middle East & Africa Antibody Drugs Sales, (mg), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Antibody Drugs Product Offerings
Table 48. Novartis Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Antibody Drugs Product Offerings
Table 51. Amgen Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 52. Bristol-Myers Squibb Corporate Summary
Table 53. Bristol-Myers Squibb Antibody Drugs Product Offerings
Table 54. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 55. F. Hoffmann-La Roche Corporate Summary
Table 56. F. Hoffmann-La Roche Antibody Drugs Product Offerings
Table 57. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Antibody Drugs Product Offerings
Table 60. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 61. AbbVie Corporate Summary
Table 62. AbbVie Antibody Drugs Product Offerings
Table 63. AbbVie Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly Antibody Drugs Product Offerings
Table 66. Eli Lilly Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Antibody Drugs Product Offerings
Table 69. Pfizer Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 70. Bayer Corporate Summary
Table 71. Bayer Antibody Drugs Product Offerings
Table 72. Bayer Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 73. GlaxoSmithKline Corporate Summary
Table 74. GlaxoSmithKline Antibody Drugs Product Offerings
Table 75. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 76. Sanofi Corporate Summary
Table 77. Sanofi Antibody Drugs Product Offerings
Table 78. Sanofi Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2017-2022)
Table 79. Antibody Drugs Production Capacity (mg) of Key Manufacturers in Global Market, 2020-2022 (mg)
Table 80. Global Antibody Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Antibody Drugs Production by Region, 2017-2022 (mg)
Table 82. Global Antibody Drugs Production by Region, 2023-2028 (mg)
Table 83. Antibody Drugs Market Opportunities & Trends in Global Market
Table 84. Antibody Drugs Market Drivers in Global Market
Table 85. Antibody Drugs Market Restraints in Global Market
Table 86. Antibody Drugs Raw Materials
Table 87. Antibody Drugs Raw Materials Suppliers in Global Market
Table 88. Typical Antibody Drugs Downstream
Table 89. Antibody Drugs Downstream Clients in Global Market
Table 90. Antibody Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Antibody Drugs Segment by Type
Figure 2. Antibody Drugs Segment by Application
Figure 3. Global Antibody Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibody Drugs Sales in Global Market: 2017-2028 (mg)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Drugs Revenue in 2021
Figure 9. By Type - Global Antibody Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibody Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibody Drugs Price (USD/mg), 2017-2028
Figure 12. By Application - Global Antibody Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Antibody Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antibody Drugs Price (USD/mg), 2017-2028
Figure 15. By Region - Global Antibody Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibody Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibody Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibody Drugs Sales Market Share, 2017-2028
Figure 19. US Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibody Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibody Drugs Sales Market Share, 2017-2028
Figure 24. Germany Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibody Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibody Drugs Sales Market Share, 2017-2028
Figure 33. China Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibody Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibody Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibody Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibody Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibody Drugs Production Capacity (mg), 2017-2028
Figure 49. The Percentage of Production Antibody Drugs by Region, 2021 VS 2028
Figure 50. Antibody Drugs Industry Value Chain
Figure 51. Marketing Channels